These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1297336)

  • 41. Analysis of DNA binding by the adenovirus type 5 E1A oncoprotein.
    Avvakumov N; Sahbegovic M; Zhang Z; Shuen M; Mymryk JS
    J Gen Virol; 2002 Mar; 83(Pt 3):517-524. PubMed ID: 11842246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino acids 1-29 of the adenovirus serotypes 12 and 2 E1A proteins interact with rap30 (TF(II)F) and TBP in vitro.
    Lipinski KS; Esche H; Brockmann D
    Virus Res; 1998 Mar; 54(1):99-106. PubMed ID: 9660075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation.
    Smits PH; de Wit L; van der Eb AJ; Zantema A
    Oncogene; 1996 Apr; 12(7):1529-35. PubMed ID: 8622869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.
    Sauthoff H; Pipiya T; Heitner S; Chen S; Bleck B; Reibman J; Chang W; Norman RG; Rom WN; Hay JG
    Mol Ther; 2004 Oct; 10(4):749-57. PubMed ID: 15451459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1.
    Frost JR; Mendez M; Soriano AM; Crisostomo L; Olanubi O; Radko S; Pelka P
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recruitment of TRRAP required for oncogenic transformation by E1A.
    Deleu L; Shellard S; Alevizopoulos K; Amati B; Land H
    Oncogene; 2001 Dec; 20(57):8270-5. PubMed ID: 11781841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.
    Dorsman JC; Teunisse AF; Zantema A; van der Eb AJ
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():423-6. PubMed ID: 9018065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
    Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.
    Avvakumov N; Wheeler R; D'Halluin JC; Mymryk JS
    J Virol; 2002 Aug; 76(16):7968-75. PubMed ID: 12134001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural determinants in adenovirus 12 E1A involved in the interaction with C-terminal binding protein 1.
    Molloy DP; Barral PM; Bremner KH; Gallimore PH; Grand RJ
    Virology; 2000 Nov; 277(1):156-66. PubMed ID: 11062046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
    Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The E1A proteins of all six human adenovirus subgroups target the p300/CBP acetyltransferases and the SAGA transcriptional regulatory complex.
    Shuen M; Avvakumov N; Torchia J; Mymryk JS
    Virology; 2003 Nov; 316(1):75-83. PubMed ID: 14599792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu.
    Chen H; Yu D; Chinnadurai G; Karunagaran D; Hung MC
    Oncogene; 1997 Apr; 14(16):1965-71. PubMed ID: 9150363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding.
    Routes JM; Li H; Bayley ST; Ryan S; Klemm DJ
    J Immunol; 1996 Feb; 156(3):1055-61. PubMed ID: 8557979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
    Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
    Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interaction of adenovirus E1A with the mammalian protein Ku70/XRCC6.
    Frost JR; Olanubi O; Cheng SK; Soriano A; Crisostomo L; Lopez A; Pelka P
    Virology; 2017 Jan; 500():11-21. PubMed ID: 27769014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenovirus-5 E1A: paradox and paradigm.
    Frisch SM; Mymryk JS
    Nat Rev Mol Cell Biol; 2002 Jun; 3(6):441-52. PubMed ID: 12042766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational and functional analysis of an essential subdomain of the adenovirus E1A N-terminal transcription repression domain.
    Loewenstein PM; Arackal S; Green M
    Virology; 2006 Aug; 351(2):312-21. PubMed ID: 16678877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation.
    Cohen MJ; Yousef AF; Massimi P; Fonseca GJ; Todorovic B; Pelka P; Turnell AS; Banks L; Mymryk JS
    J Virol; 2013 Sep; 87(18):10348-55. PubMed ID: 23864635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.